← Leaderboards
Ann M Arvin
Stanford University
$18,980,456
Attributed
$18,980,456
Total exposure
19
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.4M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$39,654,677 · 21
By mechanism
U19$17,380,996 · 3
R01$13,618,737 · 5
P01$5,388,292 · 4
R37$1,977,373 · 1
R21$441,429 · 1
R56$405,861 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Mark A Kay$46,920,488
- Harry Bernard Greenberg$91,083,131
- Mark M Davis$39,722,191
- Bali Pulendran$71,035,530
- Peter Sarnow$27,278,753
Others in their field
Top investigators on “Skin”
- David Heimbrook · Leidos Biomedical Research, Inc.$121,104,269
- Donald Ym Leung · University Of Colorado Denver$58,473,424
- Thomas S. Kupper · Dana-Farber Cancer Institute$53,329,207
- Elaine Fuchs · University Of Chicago$41,573,105
- Timothy Burgess · National Institute Of Allergy And Infectious Diseases$35,600,000
- David Leung · National Jewish Health$31,859,607
Research focus
SkinVaccinesInfectionVirusVirus ReplicationCellsNeuronsClinical ResearchVirus DiseasesT-LymphocyteResponseProteinsResearch StudyXenograft ProcedureChickenpoxCytokineIn VivoHuman SubjectMutantMolecularHuman Herpesvirus 3Mouse ModelPathogenesisTissues
Grant awards (75)
Varicella-Zoster Virus: T Cell/Skin Tropisms & Immunity$395,540
R37 · FY2020 · AI · contact PI
Varicella-Zoster Virus: T Cell/Skin Tropisms & Immunity$395,505
R37 · FY2019 · AI · contact PI
Varicella-Zoster Virus: T Cell/Skin Tropisms & Immunity$395,473
R37 · FY2018 · AI · contact PI
Varicella-Zoster Virus: T Cell/Skin Tropisms & Immunity$395,441
R37 · FY2017 · AI · contact PI
Varicella-Zoster Virus: T Cell/Skin Tropisms & Immunity$395,414
R37 · FY2016 · AI · contact PI
Varicella zoster virus: molecular controls of cell fusion-dependent pathogenesis$392,754
R01 · FY2016 · AI · contact PI
The Role of the LAT Locus in HSV-1 Infection of Human Skin Xenografts In Vivo$405,861
R56 · FY2015 · AI · contact PI
Varicella zoster virus: molecular controls of cell fusion-dependent pathogenesis$392,739
R01 · FY2015 · AI · contact PI
Varicella-Zoster Virus: T Cell/Skin Tropism & Immunity$438,199
R01 · FY2014 · AI · contact PI
Varicella zoster virus: molecular controls of cell fusion-dependent pathogenesis$392,725
R01 · FY2014 · AI · contact PI
Varicella-Zoster Virus: T Cell/Skin Tropism & Immunity$411,906
R01 · FY2013 · AI · contact PI
Varicella zoster virus: molecular controls of cell fusion-dependent pathogenesis$369,150
R01 · FY2013 · AI · contact PI
Varicella-zoster Virus: Tegument Proteins in Pathogenesis$466,116
R01 · FY2012 · AI · contact PI
Varicella-Zoster Virus: T Cell/Skin Tropism & Immunity$438,199
R01 · FY2012 · AI · contact PI
Varicella zoster virus: molecular controls of cell fusion-dependent pathogenesis$392,700
R01 · FY2012 · AI · contact PI
Varicella-zoster Virus: Tegument Proteins in Pathogenesis$466,315
R01 · FY2011 · AI · contact PI
Varicella-Zoster Virus: T Cell/Skin Tropism & Immunity$439,019
R01 · FY2011 · AI · contact PI
Protective Immunity Against Herpesvirus Infections$243,107
P01 · FY2011 · CA · contact PI
Varicella-zoster Virus: Tegument Proteins in Pathogenesis$475,786
R01 · FY2010 · AI · contact PI
Varicella-Zoster Virus: T Cell/Skin Tropism & Immunity$461,409
R01 · FY2010 · AI · contact PI
Investigation of herpes simplex virus -1 neurotropism in SCID DRG xenografts$239,536
R21 · FY2010 · AI · contact PI
Protective Immunity Against Herpesvirus Infections$208,105
P01 · FY2010 · CA · contact PI
Varicella-zoster Virus: Tegument Proteins in Pathogenesis$74,028
R01 · FY2010 · AI · contact PI
Varicella-zoster Virus: Tegument Proteins in Pathogenesis$505,770
R01 · FY2009 · AI · contact PI
Varicella-Zoster Virus: T Cell/Skin Tropisms & Immunity$364,650
R01 · FY2009 · AI · contact PI
Protective Immunity Against Herpesvirus Infections$204,551
P01 · FY2009 · CA · contact PI
Investigation of herpes simplex virus -1 neurotropism in SCID DRG xenografts$201,893
R21 · FY2009 · AI · contact PI
Protective Mechanisms Against Pandemic Respiratory Virus$3,156,407
U19 · FY2008 · AI · contact PI
Varicella-Zoster Virus: T Cell/Skin Tropisms & Immunity$364,578
R01 · FY2008 · AI · contact PI
Protective Immunity Against Herpesvirus Infections$198,751
P01 · FY2008 · CA · contact PI
CD8 T cell Immunity to Influenza$161,900
U19 · FY2008 · AI · contact PI
Pilot Projects Component (Pilot Proj 2: Guccione)$118,218
U19 · FY2008 · AI · contact PI
Protective Mechanisms Against Pandemic Respiratory Virus$3,054,173
U19 · FY2007 · AI · contact PI
Varicella-zoster Virus Tegument Proteins in Pathogenesis$420,322
R01 · FY2007 · AI · contact PI
Ontogeny of Measles Immunity in Infants$385,871
U01 · FY2007 · AI · contact PI
Varicella-Zoster Virus: T Cell/Skin Tropisms & Immunity$371,569
R01 · FY2007 · AI · contact PI
Protective Immunity Against Herpesvirus Infections$176,640
P01 · FY2007 · CA · contact PI
Protective Mechanisms Against Pandemic Respiratory Virus$3,066,309
U19 · FY2006 · AI · contact PI
Varicella-zoster Virus Tegument Proteins in Pathogenesis$420,243
R01 · FY2006 · AI · contact PI
Ontogeny of Measles Immunity in Infants$385,820
R01 · FY2006 · AI · contact PI
Varicella-Zoster Virus: T Cell/Skin Tropisms & Immunity$382,596
R01 · FY2006 · AI · contact PI
Protective Mechanisms Against Pandemic Respiratory Virus$3,121,975
U19 · FY2005 · AI
Varicella-zoster Virus Tegument Proteins in Pathogenesis$417,796
R01 · FY2005 · AI
Ontogeny of Measles Immunity in Infants$399,705
R01 · FY2005 · AI
Varicella-Zoster Virus: T Cell/Skin Tropisms &Immunity$334,368
R01 · FY2005 · AI
ANTIVIRAL IMMUNE MECHANISMS IN EARLY CHILDHOOD$1,002
M01 · FY2005 · RR
Protective Mechanisms Against Pandemic Respiratory Virus$3,126,720
U19 · FY2004 · AI
Varicella-zoster Virus Tegument Proteins in Pathogenesis$405,618
R01 · FY2004 · AI
Acquisition of Human Cytomegalovirus in Preterm, LBW$9,645
M01 · FY2004 · RR
Antiviral Immune Mechanisms in Early Childhood$2,667
M01 · FY2004 · RR
Protective Mechanisms Against Pandemic Respiratory Virus$1,575,294
U19 · FY2003 · AI
ANTI-VIRAL IMMUNE MECHANISMS IN EARLY CHILDHOOD$855,794
P01 · FY2003 · AI
Varicella-zoster Virus Tegument Proteins in Pathogenesis$420,519
R01 · FY2003 · AI
VARICELLA ZOSTER VIRUS--T CELL/SKIN TROPISMS AND IMMUNIT$324,963
R01 · FY2003 · AI
ONTOGENY OF MEASLES IMMUNITY IN INFANTS$317,275
R01 · FY2003 · AI
ANTI-VIRAL IMMUNE MECHANISMS IN EARLY CHILDHOOD$1,195,461
P01 · FY2002 · AI
VARICELLA ZOSTER VIRUS--T CELL/SKIN TROPISMS AND IMMUNIT$297,140
R01 · FY2002 · AI
ONTOGENY OF MEASLES IMMUNITY IN INFANTS$291,303
R01 · FY2002 · AI
Evolution of CD8 T cell responses to HCMV in infants$187,449
P01 · FY2002 · AI
PROTECTIVE IMMUNITY TO VARICELLA ZOSTER VIRUS AFTER BONE MARROW TRANSPLANTATION$0
P01 · FY2002 · CA
ANTI-VIRAL IMMUNE MECHANISMS IN EARLY CHILDHOOD$772,291
P01 · FY2001 · AI
VIRAL GASTROENTERITIS--BASIS OF PROTECTION AND VIRULENCE$379,749
R01 · FY2001 · AI
VARICELLA ZOSTER VIRUS--T CELL/SKIN TROPISMS AND IMMUNIT$308,309
R01 · FY2001 · AI
ONTOGENY OF MEASLES IMMUNITY IN INFANTS$299,452
R01 · FY2001 · AI
Evolution of CD8 T cell responses to HCMV in infants$187,449
P01 · FY2001 · AI
Phenotype of B Cells Induced by Rotavirus Infection$41,600
R03 · FY2001 · TW
PROTECTIVE IMMUNITY TO VARICELLA ZOSTER VIRUS AFTER BONE MARROW TRANSPLANTATION$0
P01 · FY2001 · CA
ANTI-VIRAL IMMUNE MECHANISMS IN EARLY CHILDHOOD$749,797
P01 · FY2000 · AI
VARICELLA ZOSTER VIRUS--T CELL/SKIN TROPISMS AND IMMUNIT$305,019
R01 · FY2000 · AI
ONTOGENY OF MEASLES IMMUNITY IN INFANTS$290,928
R01 · FY2000 · AI
PROTECTIVE IMMUNITY TO VARICELLA ZOSTER VIRUS AFTER BONE MARROW TRANSPLANTATION$221,448
P01 · FY2000 · CA
Evolution of CD8 T cell responses to HCMV in infants$187,449
P01 · FY2000 · AI
AGE RELATED DIFFERENCES IN CELL MEDIATED IMMUNE RESPONSE TO VZV$602
M01 · FY2000 · RR
TREATMENT OF HERPES SIMPLEX INFECTIONS$602
M01 · FY2000 · RR
PROTECTIVE IMMUNITY TO VARICELLA ZOSTER VIRUS AFTER BONE MARROW TRANSPLANTATION$0
P01 · FY2000 · CA